Summary
5-Hydroxytryptamine (5 HT)-induced contractions were investigated on cocaine-treated strips of bovine large coronary arteries.
-
1.
The α2-adrenoceptor blockers rauwolscine and yohimbine antagonized competitively 5 HT-induced contractions. The estimated equilibrium dissociation constantsK B (−log mol/l) were 7.1 for rauwolscine and 7.3 for yohimbine. The affinity of yohimbine for the receptors mediating the response to 5HT appears to be 10 times higher than for postsynaptic α1-adrenoceptor but 10 times lower than for postsynaptic vascular α2-adrenoceptor.
-
2.
(−)-Noradrenaline and the α2-adrenoceptor agonist B-HT 920 caused maximum contractions amounting to only 20% and 2%, respectively, of the maximum 5 HT effects. Neither 60 μmol/l B-HT 920 nor 1 μmol/l prazosin antagonized the 5 HT effect.
-
3.
Ketanserin was a competitive antagonist (K B=9.2 (−log mol/l)) of the effects of 5 HT. Combinations of rauwolscine or yohimbine with ketanserin antagonized the 5 HT effects as expected from competition of the 4 drugs for a single class of receptor.
-
4.
The evidence is consistent with an interaction of 5 HT, ketanserin, rauwolscine and yohimbine with 5 HT2 receptors. α-Adrenoceptors only play a minor role in large coronary arteries and appear not to be involved in the 5 HT-induced contractions. A possible clinical involvement of 5 HT in coronary artery spasm is discussed.
Similar content being viewed by others
References
Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonism. Br J Pharmacol 14:48–58
Awouters F, Leysen JE, De Clerck F, van Nueten JM (1982) General pharmacological profile of ketanserin (R 41468), a selective 5-HT2 receptor antagonist. In: De Clerck F, Vanhoutte PM (eds) 5-Hydroxytryptamine in peripheral reactions. Raven Press, New York, pp. 193–197
Blinks JR (1965) Convenient apparatus for recording contractions of isolated muscle. J Appl Physiol 20:755–757
Brazenor RM, Angus JA (1981) Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: No role for alpha adrenoceptors. J Pharmacol Exp Ther 218:530–536
Brazenor RM, Angus JA (1982) Actions of serotonin antagonists on dog coronary artery. Eur J Pharmacol 81:569–576
Consolazione A, Milstein C, Wright B, Cuello AC (1981) Immunocytochemical detection of serotonin with monoclonal antibodies. J Histochem Cytochem 29:1425–1430
Constantine JW, Lebel W, Archer R (1982) Functional postsynaptic β but not α1-adrenoceptor in dog saphenous vein exposed to phenoxybenzamine. Eur J Pharmacol 85:325–329
De Mey J, Vanhoutte PM (1981) Uneven distribution of postjunctional alpha1- and alpha2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res 48:875–884
Feniuk W, Humphrey PPA, Watts AD (1981) Further characterization of pre- and post-junctional receptor for 5-hydroxytryptamine in isolated vasculature. Br J Pharmacol 73:191P-192P
Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br Pharmacol 12:323–328
Holtz J, Saeed M, Sommer O, Bassenge E (1982) Norepinephrine constricts the canine coronary bed via postsynaptic α2-adrenoceptor. Eur J Pharmacol 82:199–202
Innes IR (1962) An action of 5-hydroxytryptamine on adrenaline receptors. Br J Pharmacol 19:427–442
Kaumann AJ (1982) Yohimbine, rauwolscine and ketanserin antagonize 5HT contractures through the same receptors in large coronary arteries of calf. Pflügers Arch 394:R89
Kaumann AJ, Mc Inerny T, Gilmour DP, Blinks JR (1980) Comparative assessment of β-receptor blocking agents as simple competitive antagonists in isolated heart muscle. Similarity of inotropic and chronotropic blocking potencies against isoproterenol. Naunyn-Schmiedeberg's Arch Pharmacol 311:219–236
Kaumann AJ, Breuer H-WM, Arnold G (1982) Heterogeneous spare receptors for serotonin (5HT) in bovine coronary arteries. Pflügers Arch 392:R36
Lambert GA, Lang WJ, Friedman E, Meller E, Gershon S (1978) Pharmacological and biochemical properties of isomeric yohimbine alkaloids. Eur J Pharmacol 49:39–48
Lemoine H, Kaumann AJ (1982) A novel analysis of concentration-dependence of partial agonism. Ring-demethylation of bupranolol results in a high-affinity partial agonist (K 105) for myocardial and tracheal β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 320:130–144
Lemoine H, Kaumann AJ (1983) A model for the interaction of antagonists with two receptor-subtypes characterized by a Schildplot with apparent slope unity. Agonist-dependent enantiomeric affinity ratios for bupranolol in trachae but not in right atria of guinea pigs. Naunyn-Schmiedeberg's Arch Pharmacol 322:111–120
Leysen JE, Awouters F, Kenis L, Laduron PM, Vandenberg J, Janssen PAJ (1981) Receptor binding profile of R 41468, a novel antagonist at 5HT2 receptors. Life Sci 28:1015–1022
Leysen JE, Niemegeers CJE, van Nueten JM, Laduron PM (1982) [3H]Ketanserin (R 41468), a selective3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol 21:301–314
Lues I, Schümann HJ (1982) Characterization of postsynaptic α-adrenoceptors in the isolated saphenous vein of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 321:R65
Mena MA, Vidrio H (1976) On the mechanism of the coronary dilator effect of serotonin in the dog. Eur J Pharmacol 36:1–5
Morris TH, Sandrock K, Kaumann AJ (1981)3H-(−)-bupranolol (3H-Bu), a new β-adrenoceptor radioligand: Binding to cat heart β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 317:19–25
Nickerson M (1971) Drugs inhibiting adrenergic nerves and structures innervated by them. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 4th edition. Collier-MacMillan, pp 549–584
Paton WDM, Rand HP (1965) The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors. Proc Roy Soc Ser B (London) 163:1–44
Peroutka ST, Snyder SH (1979) Multiple serotonin receptors: Differential binding of (3H)5-hydroxytryptamine, (3H)lysergic acid diethylamine and (3H)spiroperidol. Mol Pharmacol 16:687–699
Porquet M-F, Pourrias B, Santamaria R (1982) Effects of 5-hydroxytryptamine on canine isolated coronary arteries. Br J Pharmacol 75:305–310
Shepperson NB, Langer SZ (1981) The effects of the 2-amino-tetrahydronaphthalene derivative M7, a selective α2-adrenoceptor in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 318:10–13
Snipes RL, Thoenen H, Tanzer JP (1968) Fine structure localization of exogeneous 5-HT in vesicles of adrenergic nerve terminals. Experientia (Basel) 24:1026–1027
Starke K (1981) α-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 88:199–235
Thoa NB, Eccleston D, Axelrod J (1969) The accumulation of14C-serotonin in the guinea-pig vas deferens. J Pharmacol Exp Ther 169:68–73
Timmermans PBMWM, de Jonge A, van Meel JCA, Slothorst-Grisdijk FP, Lam E, van Zwieten PA (1981) Characterization of α-adrenoceptor populations. Quantitative relationships between cardiovascular effects initiated at central and peripheral α-adrenoceptors. J Med Chem 24:502–507
Van Meel JCA, de Jonge A, Kalkman HO, Wilffert B, Timmermans PBMWM, van Zwieten PA (1981) Vascular smooth muscle contraction initiated by postsynaptic α-adrenoceptor activations is induced by an influx of extracellular calcium. Eur J Pharmacol 69:205–212
Van Nueten JM, Janssen PAJ, van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effects of ketanserin (R 41468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther 218:217–230
Weitzell R, Tanaka T, Starke K (1979) Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 308:127–136
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaumann, A.J. Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 323, 149–154 (1983). https://doi.org/10.1007/BF00634263
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00634263